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In MS, while the frequency of relapses decreases with aging, recovery from relapses also decreases. 1 Since spontaneous recovery is more evident in younger individuals, not surprisingly a positive impact on recovery is easier to detect in patients older than the third decade. 2 As compact white matter myelination terminates by the fourth decade, ensuing insidious white matter integrity loss 3 likely leads to impairment of white matter reserve. A gradual switch from active to inactive plaques and a "rise" in the smoldering plaques are observed in the fifth decade. 4 Smoldering plaques and enlarging lesions are hallmarks of progressive MS. Mean age at clinical onset of progressive MS is also in the fifth decade. 5 Clinical progressive phase of MS is preprogression agnostic with seemingly no impact of density of relapses on the age at onset of progressive phase. In many patients, imaging findings during the asymptomatic phase of radiologically isolated syndrome (RIS) preceding primary progressive multiple sclerosis (PPMS) 6 are indistinguishable from imaging findings during the relapsing-remitting phase preceding secondary progressive multiple sclerosis (SPMS). However, a poor recovery from early B Zeydan and OH Kantarci relapses can set up an individual for earlier clinical progressive MS onset, 7 and even a single asymptomatic critical lesion can set a progressive phase in motion. The decreasing efficacy of disease-modifying therapies (DMTs) with advancing age 8 is likely due to a simultaneous decrease in relapses and increase in clinical progressive MS.
Population level generalizations can form guidelines, but they may not reflect the individual variability. A ski-racer's precision needs will make her or him recognize symptoms long before an individual with only day-to-day functioning demands. In addition, subclinical progression likely starts long before clinical progression is evident. Gray matter volume loss starts as early as the RIS phase, predominantly in the critical relays such as thalamus. 9 Cervical spinal cord volume loss is already evident at the time of progressive MS onset when compared to age-matched individuals with RIS or relapsing-remitting multiple sclerosis (RRMS). 10 Dr Scalfari emphasizes that the variability in age-dependent asymptomatic sub-clinical neurodegeneration, exhaustion of the brain reserve and repair capacity are likely to cause individual variability in patients. 11 Dr Scalfari points out that despite the very young onset of pediatric RRMS, patients only evolve to SPMS in adult age, with very rare cases of PPMS in children. Drs McGinley and Ontaneda argue that since pediatric MS patients show significant magnetic resonance imaging progression despite young age and short disease duration, this is evidence against age dependence of progression. 12 They also highlight that early imaging changes in RIS provide evidence of progression. They argue that disability outcomes are dependent on T2 lesion volume accumulation independent of age. However, the definition of progressive MS is the insidious and irreversible worsening of neurologic function for at least 1 year unexplained by other causes.
To avoid confusion, we prefer not to use "disability worsening" and "progression" terms interchangeably. Disability worsening can be due to incomplete recovery from relapses or a progressive disease course. 
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